Annual report
7634.TEDINET S100YHH0
Period2025-04-01 → 2026-03-31
Filed2026-06-24
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥15.5bn | 2025-04-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥15.1bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥14.8bn | 2023-04-01 → 2024-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥13.8bn | 2022-04-01 → 2023-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥12.8bn | 2021-04-01 → 2022-03-31v | Cons. | Net sales (5-year summary) |
| Operating income | ¥1.9bn | 2025-04-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥2.0bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥2.0bn | 2025-04-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.1bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.0bn | 2023-04-01 → 2024-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.8bn | 2022-04-01 → 2023-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.6bn | 2021-04-01 → 2022-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.0bn | 2025-04-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥2.1bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.4bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.5bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.4bn | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.3bn | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.1bn | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥1.4bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥1.5bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥26.7bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥24.6bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥23.0bn | at 2024-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥21.2bn | at 2023-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥20.3bn | at 2022-03-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥6.4bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥5.9bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥20.3bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥18.7bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥17.4bn | at 2024-03-31v | Cons. | Net assets |
| Net assets / equity | ¥15.6bn | at 2023-03-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥14.5bn | at 2022-03-31v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥11.2bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.6bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.9bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.9bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.8bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.0bn | at 2023-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥8.7bn | at 2022-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥2.5bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.2bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.4bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.3bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.0bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥1.5bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥5.3bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥745m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.1bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥690m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥948m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥740m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥903m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥958m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥937m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥439.59 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥469.18 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥450.7 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥402.98 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥358.33 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥6,401.95 | at 2026-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥5,900.59 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥5,481.61 | at 2024-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥4,931.68 | at 2023-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥4,594.54 | at 2022-03-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 74.8% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.9% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.2% | at 2024-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.3% | at 2023-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.6% | at 2022-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 7.1% | 2025-04-01 → 2026-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.2% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.7% | 2023-04-01 → 2024-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.5% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.0% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 527 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 500 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 486 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 470 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 439 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥15.4bn | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥14.9bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥12.4bn | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥11.8bn | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥10.9bn | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.7bn | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥1.8bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥1.9bn | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.9bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.7bn | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.6bn | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.4bn | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.9bn | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥2.8bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥1.3bn | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥2.2bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥1.2bn | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.1bn | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥971m | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥25.5bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥23.5bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥20.4bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥19.1bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥18.2bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥6.7bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥6.2bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥18.8bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥17.3bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥15.2bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥13.8bn | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥12.8bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥10.5bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥9.8bn | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥420.83 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥713.56 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥387.91 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥350.09 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥314.16 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥90 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥70 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥70 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥55 | 2021-04-01 → 2022-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥6,008.42 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥5,554.25 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥4,877.89 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥4,422.06 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥4,123.08 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 73.6% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.8% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.7% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.1% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.6% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 7.3% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 13.7% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.3% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.2% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.8% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 3,420,000 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 3,420,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 3,420,000 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 3,420,000 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 3,420,000 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 453 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 428 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 339 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 334 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 313 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 102
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2025-04-01 → 2026-03-31 | ¥3m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2025-04-01 → 2026-03-31 | ¥1m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-04-01 → 2026-03-31 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-04-01 → 2026-03-31 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2026-03-31 | ¥62m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-04-01 → 2026-03-31 | ¥136m |
| Care Welfare Relatedreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥26m |
| Care Welfare Relatedreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥20m |
| Care Welfare Relatedreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥1.2bn |
| Care Welfare Relatedreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥1.2bn |
| Care Welfare Relatedreportable segment | segment assets | at 2026-03-31 | ¥338m |
| Care Welfare Relatedreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥61m |
| Home Medical Treatment Relatedreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥954m |
| Home Medical Treatment Relatedreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥696m |
| Home Medical Treatment Relatedreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥7.2bn |
| Home Medical Treatment Relatedreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥7.2bn |
| Home Medical Treatment Relatedreportable segment | segment assets | at 2026-03-31 | ¥2.8bn |
| Home Medical Treatment Relatedreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥999m |
| Medical Gas Equipment Installation Relatedreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥22m |
| Medical Gas Equipment Installation Relatedreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥10m |
| Medical Gas Equipment Installation Relatedreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥1.8bn |
| Medical Gas Equipment Installation Relatedreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥1.7bn |
| Medical Gas Equipment Installation Relatedreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥80m |
| Medical Gas Equipment Installation Relatedreportable segment | segment assets | at 2026-03-31 | ¥334m |
| Medical Gas Equipment Installation Relatedreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥276m |
| Medical Gas Relatedreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥242m |
| Medical Gas Relatedreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥158m |
| Medical Gas Relatedreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥3.9bn |
| Medical Gas Relatedreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥3.9bn |
| Medical Gas Relatedreportable segment | segment assets | at 2026-03-31 | ¥1.7bn |
| Medical Gas Relatedreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥462m |
| Nursing Homereportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥19m |
| Nursing Homereportable segment | employees | at 2026-03-31 | 17 pure |
| Nursing Homereportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥350m |
| Nursing Homereportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥350m |
| Nursing Homereportable segment | segment assets | at 2026-03-31 | ¥1.2bn |
| Nursing Homereportable segment | segment profit | 2025-04-01 → 2026-03-31 | −¥16m |
| —segment total | capex | 2025-04-01 → 2026-03-31 | ¥1.2bn |
| —segment total | depreciation | 2025-04-01 → 2026-03-31 | ¥902m |
| —segment total | revenue | 2025-04-01 → 2026-03-31 | ¥14.5bn |
| —segment total | revenue external | 2025-04-01 → 2026-03-31 | ¥14.4bn |
| —segment total | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥80m |
| —segment total | segment assets | at 2026-03-31 | ¥6.4bn |
| —segment total | segment profit | 2025-04-01 → 2026-03-31 | ¥1.8bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2025-04-01 → 2026-03-31 | ¥1.2bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2025-04-01 → 2026-03-31 | ¥904m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2026-03-31 | ¥15.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2026-03-31 | ¥15.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥80m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2026-03-31 | ¥6.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2026-03-31 | ¥1.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2024-04-01 → 2025-03-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2024-04-01 → 2025-03-31 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2025-03-31 | ¥1.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2025-03-31 | ¥1.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2025-03-31 | ¥72m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2025-03-31 | ¥141m |
| Care Welfare Relatedreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥48m |
| Care Welfare Relatedreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥19m |
| Care Welfare Relatedreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥1.2bn |
| Care Welfare Relatedreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥1.2bn |
| Care Welfare Relatedreportable segment | segment assets | at 2025-03-31 | ¥350m |
| Care Welfare Relatedreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥44m |
| Home Medical Treatment Relatedreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥900m |
| Home Medical Treatment Relatedreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥592m |
| Home Medical Treatment Relatedreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥6.7bn |
| Home Medical Treatment Relatedreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥6.7bn |
| Home Medical Treatment Relatedreportable segment | segment assets | at 2025-03-31 | ¥2.6bn |
| Home Medical Treatment Relatedreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥907m |
| Medical Gas Equipment Installation Relatedreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥22m |
| Medical Gas Equipment Installation Relatedreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥9m |
| Medical Gas Equipment Installation Relatedreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥1.9bn |
| Medical Gas Equipment Installation Relatedreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥1.9bn |
| Medical Gas Equipment Installation Relatedreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥86m |
| Medical Gas Equipment Installation Relatedreportable segment | segment assets | at 2025-03-31 | ¥284m |
| Medical Gas Equipment Installation Relatedreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥272m |
| Medical Gas Relatedreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥325m |
| Medical Gas Relatedreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥146m |
| Medical Gas Relatedreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥4.0bn |
| Medical Gas Relatedreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥4.0bn |
| Medical Gas Relatedreportable segment | segment assets | at 2025-03-31 | ¥1.7bn |
| Medical Gas Relatedreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥636m |
| Nursing Homereportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥19m |
| Nursing Homereportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥331m |
| Nursing Homereportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥331m |
| Nursing Homereportable segment | segment assets | at 2025-03-31 | ¥1.2bn |
| Nursing Homereportable segment | segment profit | 2024-04-01 → 2025-03-31 | −¥18m |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥1.3bn |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥785m |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥14.2bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥14.1bn |
| —segment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥86m |
| —segment total | segment assets | at 2025-03-31 | ¥6.1bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥1.8bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-04-01 → 2025-03-31 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-04-01 → 2025-03-31 | ¥787m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2025-03-31 | ¥15.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2025-03-31 | ¥15.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥86m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-03-31 | ¥6.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2025-03-31 | ¥2.0bn |
| Nursing Homereportable segment | employees | at 2026-03-31 | 17 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,564
| Item | Context | Value | Unit |
|---|---|---|---|
| Average number of temporary workers | Prior4YearInstant_NonConsolidatedMember | 77 | |
| Average number of temporary workers | Prior3YearInstant_NonConsolidatedMember | 76 | |
| Average number of temporary workers | Prior2YearInstant_NonConsolidatedMember | 79 | |
| Average number of temporary workers | Prior1YearInstant_NonConsolidatedMember | 92 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 93 | |
| Total shareholder return | Prior4YearInstant_NonConsolidatedMember | 0.8999 | |
| Total shareholder return | Prior3YearInstant_NonConsolidatedMember | 1.0734 | |
| Total shareholder return | Prior2YearInstant_NonConsolidatedMember | 1.4352 | |
| Total shareholder return | Prior1YearInstant_NonConsolidatedMember | 1.2884 | |
| Total shareholder return | CurrentYearInstant_NonConsolidatedMember | 1.5020 | |
| Total return on share price index | Prior4YearInstant_NonConsolidatedMember | 1.0199 | |
| Total return on share price index | Prior3YearInstant_NonConsolidatedMember | 1.0792 | |
| Total return on share price index | Prior2YearInstant_NonConsolidatedMember | 1.5253 | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | 1.5017 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 2.0220 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row1Member | 35 | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row1Member | 30.1 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row2Member | 80 | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row2Member | 60.8 | |
| Targets description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row3Member | 60 | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row3Member | 57.5 | |
| Research and development expenses research and development activities | CurrentYearDuration | 4000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 1185000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E03330-000MedicalGasRelatedReportableSegmentsMember | 136000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration_jpcrp030000-asr_E03330-000HomeMedicalTreatmentRelatedReportableSegmentsMember | 808000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 3420000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 3420000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 3420000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 3420000 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 6 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 8 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 26 | |
| Number of shareholders foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 25 | |
| Number of shareholders foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 5 | |
| Number of shareholders individuals and others | CurrentYearInstant_OrdinaryShareMember | 860 | |
| Number of shareholders total | CurrentYearInstant_OrdinaryShareMember | 930 | |
| Number of shares held number of units national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shares held number of units financial institutions | CurrentYearInstant_OrdinaryShareMember | 2261 | |
| Number of shares held number of units financial service providers | CurrentYearInstant_OrdinaryShareMember | 394 | |
| Number of shares held number of units other corporations | CurrentYearInstant_OrdinaryShareMember | 4049 | |
| Number of shares held number of units foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 1385 | |
| Number of shares held number of units foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 7 | |
| Number of shares held number of units individuals and others | CurrentYearInstant_OrdinaryShareMember | 26055 | |
| Number of shares held number of units total | CurrentYearInstant_OrdinaryShareMember | 34151 | |
| Number of shares held shares less than one unit | CurrentYearInstant_OrdinaryShareMember | 4900 | |
| Percentage of shareholdings national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Percentage of shareholdings financial institutions | CurrentYearInstant_OrdinaryShareMember | 0.06620 | |
| Percentage of shareholdings financial service providers | CurrentYearInstant_OrdinaryShareMember | 0.01153 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |